LBRX
NASDAQ · Pharmaceuticals
Lb Pharmaceuticals Inc
$38.09
-2.76 (-6.76%)
Open$41.01
Previous Close$40.85
Day High$41.01
Day Low$37.99
52W High$50.16
52W Low$14.32
Volume—
Avg Volume348.3K
Market Cap1.28B
P/E Ratio—
EPS$-2.98
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-60.1% upside
Current
$38.09
$38.09
Target
$15.21
$15.21
$11.61
$15.21 avg
$18.52
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 167.53M | 154.99M | 171.21M |
| Net Income | 47.95M | 36.94M | 41.17M |
| Profit Margin | 28.6% | 23.8% | 24.1% |
| EBITDA | 61.52M | 61.45M | 59.09M |
| Free Cash Flow | 46.38M | 48.44M | 62.84M |
| Rev Growth | -8.2% | -9.0% | +5.4% |
| Debt/Equity | 1.06 | 1.00 | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |